TLR7和TLR8都是与病毒感染引起的免疫反应相关的胞内受体。它们识别富含GU的短单链RNA，以及咪唑喹啉和核苷类似物等人工合成的小分子。TLR7/TLR8的信号通路依赖于MyD-88的活化、AP-1和IFN-α/β等转录因子入核，以及IRF7的磷酸化。IRF7磷酸化诱导ISRE的表达和I型干扰素基因的产生，而AP-1和IFN-α/β的激活导致细胞因子的释放。
TLR7/8 激动剂相关产品：
PRODUCT | ORIGIN/DESCRIPTION | GRADE* | WORKING CONCENTRATION | QTY | CATALOG CODE |
TLR7 Agonists |
CL264 | Adenine analog | TLR2 - /TLR4 - | 50 ng - 10 µg/ml | 500 µg 5 mg | tlrl-c264e tlrl-c264e-5 |
CL307 | Hydroxyadenine spermine compound | TLR2 - /TLR4 - | 5 ng - 1 µg/ml | 500 µg | tlrl-c307 |
CL347 - AdiFectin™ | Hydroxyadenine spermine compound | TLR2 - /TLR4 - | 300 ng - 3 µg/ml | 500 µg | tlrl-c347 |
CL401 | PAM2C-conjugated hydroxyadenine compound | TLR2 + /TLR4 - | 1 ng - 10 µg/ml | 500 µg | tlrl-c401 |
CL401 VacciGrade™ | Preclinical grade CL401 | VacciGrade™ | 20 - 50 µg/mouse | 1 mg | vac-c401-5 |
CL413 - Adilipoline™ | PAM2CK4-conjugated hydroxyadenine compound | TLR2 + /TLR4 - | 50 pg - 10 µg/ml | 500 µg | tlrl-c413 |
TLR7 Agonists |
CL413 VacciGrade™ | Preclinical grade CL413 | VacciGrade™ | 20 - 50 µg/mouse | 5 mg | vac-c413-5 |
CL531 | PAM2CK4-conjugated hydroxyadenine compound | TLR2 +/ TLR4 - | 5 pg - 10 µg/ml | 500 µg | tlrl-c531 |
CL572 | Monoacyl-ethyl-cystein hydroxyadenine compound | TLR2 +/ TLR4 - | 0.5 ng - 1 µg/ml | 500 µg | tlrl-c572 |
Gardiquimod™ | Imidazoquinoline compound | TLR2 -/ TLR4 - | 0.1 - 3 µg/ml | 500 µg 5 mg | tlrl-gdqs tlrl-gdq-5 |
Imiquimod (R837) | Imidazoquinoline compound | TLR2 -/ TLR4 - | 1 - 5 µg/ml | 500 µg 5 mg | tlrl-imqs tlrl-imq |
Imiquimod VacciGrade™ | Preclinical grade Imiquimod | TLR2 -/ TLR4 - | 10 - 100 µg/mouse | 5 mg | vac-imq |
Loxoribine | Guanosine analog | TLR2 -/ TLR4 - | 1 mM (300 µg/ml) | 50 mg | tlrl-lox |
TLR8 Agonists |
ORN06/LyoVec™ | ssRNA with 6 UUGU repeats / LyoVec™ | TLR2 -/ TLR4 - | 0.25 - 5 µg/ml | 4 x 25 µg | tlrl-orn6 |
ssPolyU Naked | RNA homopolymer | TLR2 -/ TLR4 - | 1 - 10 µg/ml | 10 mg 10 x 10 mg | tlrl-sspu tlrl-sspu-100 |
ssPolyU/LyoVec™ | RNA homopolymer / LyoVec™ | TLR2 -/ TLR4 - | 1 - 10 µg/ml | 4 x 25 µg | tlrl-lpu |
ssRNA40/LyoVec™ | HIV-1 LTR-derived ssRNA / LyoVec™ | TLR2 -/ TLR4 - | 0.25 - 5 µg/ml | 4 x 25 µg | tlrl-lrna40 |
ssRNA41/LyoVec™ | ssRNA40 control / LyoVec™ | TLR2 -/ TLR4 - | 0.25 - 5 µg/ml | 4 x 25 µg | tlrl-lrna41 |
TL8-506 | Benzoazepine analog | TLR2 -/ TLR4 - | 10 - 100 ng/ml | 500 µg | tlrl-tl8506 |
TLR7/8 Agonists |
CL075 | Thiazoquinoline compound | TLR2 -/ TLR4 - | 100 ng - 5 µg/ml | 500 µg 5 mg | tlrl-c75 tlrl-c75-5 |
CL097 | Imidazoquinoline compound | TLR2 -/ TLR4 - | 50 ng - 5 µg/ml | 500 µg 5 mg | tlrl-c97 tlrl-c97-5 |
Poly(dT) | Thymidine homopolymer ODN (17 mer) | TLR2 -/ TLR4 - | 10 µM | 100 nmol | tlrl-pt17 |
R848 (resiquimod) | Imidazoquinoline compound | TLR2 -/ TLR4 - | 10 ng - 10 µg/ml | 500 µg 5 mg | tlrl-r848 tlrl-r848-5 |
R848 VacciGrade™ | Preclinical grade R848 | VacciGrade™ | 10 - 100 µg/mouse | 5 mg | vac-r848 |
更多详情请咨询Invivogen一级代理商-欣博盛生物
全国服务热线: 4006-800-892 邮箱: market@qckc0531.com
深圳: 0755-26755892 北京: 010-88594029 上海: 021-34613729
广州：020-87615159 香港: 852-69410778
代理品牌网站: www.qckc0531.com
自主品牌网站: www.neobiosescience.net